KinOmega Biopharm Inc., established in 2011 in Shifang City, Sichuan Province, manufactures and exports active pharmaceutical ingredients and bio products, with a focus on pharmaceutical-grade fish oil and other cardiovascular-related natural extracts. The company built its USDMF-registered fish oil business through a series of international certifications — HACCP and ISO in 2013, an EU registration audit in 2014 that made it an EU-approved fish oil producer, EDQM's Pharmaceutical Adaptability Certificate in 2015, a US FDA audit and 5-star IFOS certification in 2017, and cGMP site audits by Korea's and Japan's regulatory authorities in 2019 and 2022. With an experienced R&D team and strong production capacity, KinOmega serves markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen